1. Galeh TM, Sarvi S, Montazeri M, Moosazadeh M, Nakhaei M, Shariatzadeh SA, et al. Global Status of Toxoplasma gondii Seroprevalence in Rodents: A Systematic Review and Meta-Analysis. Front Vet Sci [Internet]. 2020;7. Available from: https://www.frontiersin.org/article/10.3389/fvets.2020.00461/full
2. Johnson HJ, Koshy AA. Latent Toxoplasmosis Effects on Rodents and Humans: How Much is Real and How Much is Media Hype? Garsin DA, editor. MBio [Internet]. 2020;11. Available from: https://mbio.asm.org/content/11/2/e02164-19
3. Gennari SM, Ogrzewalska MH, Soares HS, Saraiva DG, Pinter A, Nieri-Bastos FA, et al. Toxoplasma gondii antibodies in wild rodents and marsupials from the Atlantic Forest, state of São Paulo, Brazil. Rev Bras Parasitol Veterinária [Internet]. 2015;24:379–82. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-29612015000300379&lng=en&tlng=en
4. Tong WH, Pavey C, O’Handley R, Vyas A. Behavioral biology of Toxoplasma gondii infection. Parasites {\&} Vectors [Internet]. 2021;14:77. Available from: https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-020-04528-x
5. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol [Internet]. 2000;30:1217–58. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11113252